Internal Medicine, Pulmonary Disease · Huntington Beach, CA
NPI
1396958237
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
8201 Newman Ave, Suite 101
Huntington Beach, CA, 92647
Phone (714) 847-6900
Groups this clinician bills Medicare through
Medicare paid, 2024
$288K
4,432 services
Medicare patients, 2024
395
Average age 73
Drug cost, 2024
$2.4M
7,500 prescriptions
Company payments, 2025
$3,981
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robby T Ayoub was code 95004 (test - miscellaneous), 1,440 times for 17 patients. In total Robby T Ayoub billed 4,432 services in 52 codes, and Medicare paid $288K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,440 | 17 | $3.35 | $4,822 |
| 99233 Hospital E&M - Subsequent | Facility | 779 | 105 | $101.43 | $79K |
| 99215 Office E&M - Established | Office | 284 | 127 | $159.05 | $45K |
| 99309 SNF E&M | Facility | 218 | 19 | $94.29 | $21K |
| 94016 Pulmonary Function Testing | Office | 172 | 86 | $20.59 | $3,541 |
| 99214 Office E&M - Established | Office | 169 | 105 | $94.35 | $16K |
| 94010 Pulmonary Function Testing | Office | 151 | 72 | $25.44 | $3,841 |
| 99232 Hospital E&M - Subsequent | Facility | 127 | 27 | $65.17 | $8,276 |
| 94060 Pulmonary Function Testing | Office | 114 | 99 | $31.83 | $3,629 |
| 99223 Hospital E&M - Initial | Facility | 101 | 85 | $146.30 | $15K |
| 99291 Critical Care E&M | Facility | 100 | 71 | $170.21 | $17K |
| 94729 Pulmonary Function Testing | Office | 97 | 95 | $46.31 | $4,492 |
| 94726 Pulmonary Function Testing | Office | 97 | 95 | $48.12 | $4,667 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 63 | 17 | $53.60 | $3,377 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 63 | 17 | $42.41 | $2,672 |
By year: 2022 $329K for 6,377 services; 2023 $295K for 4,601 services; 2024 $288K for 4,432 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robby T Ayoub prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 912 prescriptions and refills. In total Robby T Ayoub wrote 7,500 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 912 | 1,010 | 258 | $28K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 567 | 664 | 125 | $417K |
| Montelukast Sodium Generic | 495 | 894 | 131 | $3,437 |
| Pantoprazole Sodium Generic | 226 | 413 | 64 | $1,658 |
| Prednisone Generic | 175 | 178 | 105 | $790 |
| Fluticasone Propionate Generic | 167 | 260 | 67 | $1,840 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 153 | 171 | 37 | $107K |
| Atorvastatin Calcium Generic | 143 | 321 | 43 | $1,302 |
| Breo Ellipta Fluticasone/Vilanterol | 130 | 158 | 25 | $59K |
| Roflumilast Generic | 130 | 210 | 21 | $17K |
| Levofloxacin Generic | 127 | 127 | 89 | $640 |
| Amlodipine Besylate Generic | 109 | 195 | 27 | $913 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 102 | 122 | 24 | $54K |
| Levothyroxine Sodium Generic | 98 | 126 | 12 | $1,874 |
| Eliquis Apixaban | 97 | 110 | 13 | $47K |
Brand drugs: 2,553 claims; generic drugs: 4,921 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robby T Ayoub $3,981 ($3,981 in general payments such as food, travel and fees) from 23 companies. The largest payer was GlaxoSmithKline, LLC. with $835.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 37 | $835 |
| Verona Pharma, Inc. VRNA | 22 | $508 |
| AstraZeneca Pharmaceuticals LP AZN | 18 | $475 |
| Genzyme Corporation SNY | 9 | $365 |
| Grifols USA, LLC | 19 | $350 |
| Jazz Pharmaceuticals Inc. JAZZ | 5 | $209 |
| Avadel CNS Pharmaceuticals, LLC | 10 | $207 |
| Harmony Biosciences LLC HRMY | 6 | $183 |
| Viatris Specialty LLC | 9 | $163 |
| Merck Sharp & Dohme LLC MRK | 4 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.